Worldwide Smoking-Cessation Drug Market

Tuesday, March 2, 2010 Alcohol & Drug Abuse News
Email Print This Page Comment bookmark
Font : A-A+

World Smoking-Cessation Drug Market 2010-2025 Smoking is a leading cause of preventable death worldwide. In 2009 total sales of smoking-cessation products surpassed $1.6bn (Rx products). The effects of smoking constitute a major burden on public healthcare
systems as well as lowering quality of life for many people. Currently-marketed smoking-cessation products arguably lack the desired levels of efficacy in practice with the reputation of some suffering through noted side-effects. As a result there are
significant commercial opportunities for more-efficacious and better-tolerated smoking-cessation agents especially in prescription form. ( ) The report forecasts how the anti-smoking drug market will develop over the next 15 years. We predict that the launch of new smoking-cessation aids early this decade will answer some unmet needs currently limiting that pharma market segment. Besides extensive coverage of currently-marketed drugs this report examines the most exciting products currently in development. We also include external opinions on the sector gained thorough original unique surveys. The report analyses current leading markets in North America Europe and Asia in detail. A major contribution to the market during the next 15 years will come from emerging economies led by India and China. Almost half of the world’s smokers live in those countries with almost a third in China alone reports suggest. At present those national markets yield relatively low smoking-cessation revenues. However It predicts that the emerging economies have a large potential for sales growth of smoking-cessation products. This report reveals how their sales revenues and market shares will expand during the forecast period. The majority of smokers worldwide do not have full access to smoking-cessation therapies at present. The high economic and social costs associated with tobacco use are driving anti-smoking legislation and encouraging governmental spending on tobacco-dependency treatments. From 2010 to 2025 the implementation and expansion of tobacco-control policies – especially public smoking bans – will continue. Combined those policies will help to increase the use of smoking-cessation products agents still with a long way to go in their technological and commercial development our report shows. Highlights of the report include: * Sales forecasts for the smoking-cessation drug market leading therapy types and top products at global level * Detailed examination of the smoking-cessation markets in the US Canada the UK France Germany Sweden Denmark Japan China and India with sales forecasts * Examination of strengths weakness opportunities and threats (SWOT factors) facing the industry and market * Analysis of the R&D pipeline for smoking-cessation products. To know more and to buy a copy of your report feel free to visit : Or Contact us at : Bharat Book Bureau Tel: +91 22 27578668 Fax: +91 22 27579131 Email: Website: Blog: Follow us on twitter:

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store